Cannara Biotech Inc. (LOVE.V) Research

Cannara Biotech Inc., along with its various subsidiary entities, specializes in the indoor cultivation, processing, and commercialization of cannabis and its derivative products across Canada. The company also supplies hemp-derived CBD items via its online retail platform. This enterprise was established in 2017, with its primary corporate offices situated in Saint-Laurent, Canada.

Market snapshot

Symbol
LOVE.V
Price
$1.89
Day change
+6.18%
Market cap
$163.0M
P/E ratio
13.09x
52-week range
1.06-2.07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Cardiol Therapeutics Inc. (CRDL.TO)
  • Decibel Cannabis Company Inc. (DB.V)
  • Grown Rogue International Inc. (GRIN.CN)
  • Helix BioPharma Corp. (HBP.TO)
  • HLS Therapeutics Inc. (HLS.TO)
  • Jushi Holdings Inc. (JUSH.CN)
  • Satellos Bioscience Inc. (MSCL.TO)
  • Quipt Home Medical Corp. (QIPT.TO)

Open Cannara Biotech Inc. (LOVE.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.